HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Superficial granulomatous pyoderma treated preoperatively with infliximab.

Abstract
We report a case of superficial granulomatous pyoderma (SGP) treated successfully with infliximab. A 71-year-old woman developed erythema, erosions and cribriform scarring in the right periorbital area following enucleation of the right eye. Histology showed three-layered granulomas typical of SGP. The patient's disease was unusual in that it failed to respond to a wide variety of immunosuppressants and this condition is rarely reported to affect the face. Eventually she was treated successfully with infliximab, enabling her to undergo extensive surgery despite the fact that her disease was pathergic in onset.
AuthorsV Akhras, R Sarkany, S Walsh, N Hyde, R A Marsden
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 34 Issue 5 Pg. e183-5 (Jul 2009) ISSN: 1365-2230 [Electronic] England
PMID19094137 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Infliximab
Topics
  • Aged
  • Antibodies, Monoclonal (therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Diagnosis, Differential
  • Female
  • Humans
  • Infliximab
  • Pyoderma Gangrenosum (diagnosis, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: